期刊文献+

SFRP4和β-catenin在宫颈鳞癌中的表达及其临床意义 被引量:5

Expression and clinical significance of SFRP4 and β-catenin in cervical squamous cell carcinoma
下载PDF
导出
摘要 目的观察分泌型卷曲相关蛋白(SFRP4)及β-连环素(β-catenin)在宫颈鳞癌组织中的表达,并分析其临床病理意义。方法应用免疫组化SP法检测62例宫颈鳞癌组织(SCC组)及23例正常宫颈组织(NC组)中SFRP4和β-catenin的表达。结果①(1)SCC组SFRP4和β-catenin的阳性表达率(66.1%、71.0%)均高于NC组(30.4%、34.8%)(P均<0.05)。②SFRP4和β-catenin在宫颈鳞癌中的表达与临床分期、分化程度、淋巴转移及浸润深度有关(P均<0.05)。③SFRP4和β-catenin的表达呈正相关(r=0.29,P<0.05)。结论 SFRP4可能与β-catenin协同作用促进Wnt/β-catenin信号通路的活化,并且与宫颈鳞癌的恶性临床病理特征相关,提示SFRP4可能成为指导宫颈鳞癌的临床治疗和判断预后的指标。 Objective To investigate the expression and clinical significance of SFRP4 and 13 - catenin in cervical squamous cell carcino- ma. Methods Immunohistochemistry was used to detect the expression of SFRP4 and 13 - catenin in 62 samples of cervical squamous cell carcino- ma ( SCC group) and 23 samples of normal cervix ( NC group). Results (~)The positive expression of SFRP4 and 13 - catenin were both signifi- cantly higher in SCC group than those in NC group ( P 〈 0.05 ). (~)The expression of SFRP4 and 13 - catenin in SCC group was closely associated with clinical staging, differentiation, lymphnode metastasis and depth of invasion (all P 〈 0.05 ). (~)There was a positive correlation betweem SFRP4 and 13 - catenin ( r = O. 29, P 〈 0.05 ). Conclusion The effects of SFRP4 and β - catenin were synergistic on the activation of Wnt sig- nalling pathway, and it is closely associated with clinicopathological significance of SCC. So SFRP4 may help us clinical treatment and judging prognosis.
出处 《临床和实验医学杂志》 2013年第16期1267-1268,1271,共3页 Journal of Clinical and Experimental Medicine
基金 承德市科学技术研究与发展计划项目编号(20122176)
关键词 宫颈鳞癌 SFRP4 Β-CATENIN 免疫组织化学法 Cervical squamous cell carcinoma(SCC) SFRP4 β - catenin Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献70

  • 1Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-90.
  • 2Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1: 279-88.
  • 3Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003; 22: 7218-21.
  • 4Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM, et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004; 101: 3118-23.
  • 5Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, et al. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 2003; 63: 4547-51.
  • 6Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002; 108: 837-47.
  • 7Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama SKikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 1998; 17: 1371-84.
  • 8Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu SPolakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996; 272: 1023-6.
  • 9Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002; 16: 1066-76.
  • 10Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999; 9: 207-10.

共引文献12

同被引文献52

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部